Zambia's Tembo Promises Cheaper AIDS Drugs

Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.

Zambia's Tembo Promises Cheaper AIDS Drugs

Reuters (12.28.01) - Monday, December 31, 2001
Manoah Esipisu

Zambian presidential contender Christon Tembo on the eve of Thursday's election offered a promise of cheaper AIDS drugs to help combat the epidemic. He said his Forum for Democracy and Development (FDD) would boost the fight against HIV/AIDS. An estimated 200 Zambians die from the disease every day.

"We want to assist all people to have access to cheaper drugs," Tembo told Reuters. "Our people are suffering and we must move to help them."

One in five of Zambian adults are HIV-positive. Yet Zambia remains without an AIDS policy framework document and last month the government failed to agree with the World Bank on a $42 million loan to help fight the disease. "We would have to talk with pharmaceutical companies on getting cheaper versions of their AIDS cocktails made available in Zambia. We have to examine all avenues, including generic drugs," Tembo said.

Aside from the FDD, no other political party has made AIDS an issue in the campaign. The disease kills more than 1,000 teachers every year and is expected to reduce life expectancy in Zambia to 37 years within the next decade from 46 years today.

[PNU editor's note: On Monday, Agence France Presse reported that opposition parties vowed to protest in the streets over alleged fraud in the election, while observers voiced concern over the vote count in the extremely tight race for president.]
011231
AD012259

Copyright © 2001 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.